Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
NYSE:BMY
Price:
42.34 USD
0.17%
Market Closed
Updated:
May 23, 2024
Bristol-Myers Squibb Co
Net Change in Cash
|
Bristol-Myers Squibb Co
Net Change in Cash Peer Comparison
Comparables:
JNJ
PFE
MRK
ZTS
LLY
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Change in Cash
$286m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-23%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Change in Cash
-$1.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Net Change in Cash
-$1.4B
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Net Change in Cash
-$4.1B
|
CAGR 3-Years
-111%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Zoetis Inc
NYSE:ZTS
|
Net Change in Cash
-$134m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Change in Cash
-$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-36%
|
See Also
What is Bristol-Myers Squibb Co's Net Change in Cash?
Net Change in Cash
286m
USD
286m
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Net Change in Cash amounts to 286m USD.
What is Bristol-Myers Squibb Co's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
-23%
-23%
You don't have any saved screeners yet
